Search results
AGCO (NYSE:AGCO) Price Target Cut to $133.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 1 day agoAGCO (NYSE:AGCO – Get Free Report) had its target price decreased by investment analysts at ...
Diageo plc (NYSE:DEO) Shares Purchased by Oppenheimer & Co. Inc.
ETF DAILY NEWS· 6 days agoOppenheimer & Co. Inc. boosted its stake in Diageo plc (NYSE:DEO – Free Report) by 10.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The ...
Oppenheimer & Co. Inc. Has $1.30 Million Position in Boston Properties, Inc. (NYSE:BXP)
ETF DAILY NEWS· 4 days agoOppenheimer & Co. Inc. grew its position in Boston Properties, Inc. (NYSE:BXP – Free Report) by...
Oppenheimer & Co. Inc. Decreases Stock Position in General Motors (NYSE:GM)
ETF DAILY NEWS· 4 days agoOppenheimer & Co. Inc. cut its stake in General Motors (NYSE:GM – Free Report) (TSE:GMM.U) by 22.9%...
$50M wrongful conviction case highlights decades of Chicago police forced confessions
USA Today· 3 hours agoThe payout for the "Marquette Park 4," as they became known after the infamous murder case, is the...
Quarry LP Has $303,000 Stake in AGCO Co. (NYSE:AGCO)
ETF DAILY NEWS· 5 hours agoQuarry LP raised its position in AGCO Co. (NYSE:AGCO – Free Report) by 61.9% in the 4th quarter, according to the company in its most recent filing with...
In spite of recent selling, insiders still control 44% of Oppenheimer Holdings Inc. (NYSE:OPY)
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Insiders appear to have a vested interest in Oppenheimer Holdings' growth, as seen by...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 3 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Republic Services, Inc. (NYSE:RSG) Shares Purchased by Oppenheimer & Co. Inc.
ETF DAILY NEWS· 4 days agoOppenheimer & Co. Inc. lifted its holdings in Republic Services, Inc. (NYSE:RSG – Free Report) by...
UroGen Pharma (NASDAQ:URGN) Price Target Raised to $53.50
ETF DAILY NEWS· 5 hours agoUroGen Pharma (NASDAQ:URGN – Free Report) had its price target hoisted by LADENBURG THALM/SH SH from $48.00 to $53.50 in a report published on Friday, Benzinga reports. They currently have a ...